Type2 Diabetes Mellitus
Conditions
Keywords
glucose excursions, insulin technique, insulin antibodies, premixed insulin
Brief summary
To compare patients and nurses using insulin pen injector to inject premixed insulin respectively, using continuous glucose monitoring system to evaluate the glucose excursion in the two sets, study the relationship between glucose excursion and inject technique in type 2 diabetes mellitus.
Detailed description
A total of 60 patients with type 2 diabetes who used premixed insulin will enrolled in this study.Measure their blood pressure，height and weight, BMI, liver and kidney function, blood lipids, glycosylated hemoglobin, fasting glucose, 2 hour postprandial glucose，fasting C peptide, 2 hour postprandial C peptide, fasting glucagon, 2 hour postprandial glucagon,fasting serum insulin，2 hour postprandial serum insulin，urinary albumin and insulin antibodies.The first and second days，the patients inject premixed insulin themselves，the specialist nurse graded the patient's injection technique score.The third and the fourth days the nurse change a new insulin with the same types maintain the same injection dosage.The patient need perform continuous glucose monitoring system(CGMS) for 96-hours.
Interventions
OTHERnurse inject premixed insulin
nurse inject premixed insulin，coaching in the injection technique
Sponsors
Nanjing First Hospital, Nanjing Medical University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
1. type 2 diabetes patients 2. aged 20-80 years 3. had been on premixed insulin and used an insulin pen for at least 3 months 4. fasting glucose between 6.1-16 mmolL, postprandial(or random) glucose below 22.2mmol/L. 5. No acute complications such as diabetic ketoacidosis, diabetic hypertosmolar syndrome. 6. Subjects were able and willing to ues CGMS and eat regularly. 7. Patients who were able to inject insulin themselves or actual injections can be accompanied.
Exclusion criteria
1. Insulin allergy. 2. There has been a history of drug abuse and alcohol dependence in the past five years, or systemic hormone therapy within 3 months. 3. Patients with poor compliance and irregular eating and exercise. 4. Infection or stress within four weeks. 5. Patients unable to tolerate CGMS. 6. patients with pregnancy, breast-feeding, planning to have a baby 7. patients with coagulopathy, serious complication,such as cardiovascular disease, end stage renal disease; and patients with severe retinopathy or other eye problems that impair their visual function, or cognitive dysfunction
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The primary endpoint was the relationship between MAGE and injection score | 6 DAYS | the relationship between the 24-h mean amplitude of glycemic excursions (MAGE) and injection score |
| the relationship between HbA1C and injection score | 6 DAYS | the relationship between HbA1C and injection score |
| the relationship between SDBG and injection score | 6 DAYS | the relationship between SDBG and injection score |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| the relation between insulin antibodies and glucose excursions | 6 DAYS | the 24-h mean amplitude of glycemic excursions (MAGE) |
Contacts
Primary ContactMA JIANHUA, PHD
Outcome results
None listed